Single Needle Hemodialysis
Sorensen Research
FDA Clearance Information
The single needle hemodialysis device was cleared through the FDA 510k pathway on December 6, 1976. It is manufactured by Sorensen Research and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- For use in hemodialysis using a single-needle vascular access technique.
- For extracorporeal circulation of blood during dialysis treatment when the prescribed dialysis system supports single-needle operation.
Clinical Applications
- Single-needle hemodialysis through an appropriate vascular access.
- Hemodialysis when a single-needle technique is selected by the treating dialysis team.
- Extracorporeal blood flow during a prescribed hemodialysis treatment.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The device must be used with compatible dialysis blood tubing, pumps, monitors, and the prescribed hemodialysis machine.
- Single-needle dialysis uses alternating blood withdrawal and return through one access site, so treatment settings and access function must be monitored closely.
- The access may be an arteriovenous fistula, arteriovenous graft, or another access specified by the dialysis team; suitability depends on blood-flow capability and access condition.
- The record identifies a Class II device cleared through the 510(k) pathway; it does not provide current dimensions, sizes, materials, MRI labeling, or a universal service life.
- Contraindications and warnings should be taken from the device labeling and dialysis-system instructions. General concerns include inadequate vascular access, clotting, blood loss, infection, air entry, and hemodynamic instability.
Frequently Asked Questions
What are the clinical indications for single needle hemodialysis?
The device is indicated for patients requiring hemodialysis, particularly those with challenging vascular access or cardiovascular conditions.
What outcomes have been reported in clinical studies?
Studies report comparable efficiency to double-needle systems, with variations in clearance rates and patient satisfaction.
What complications have been reported?
Safety data indicate potential vascular access issues and the need for careful dialysis parameter monitoring.